We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Neural Network Recognizes Breast Cancer on Histological Samples With 100% Accuracy

By LabMedica International staff writers
Posted on 02 Feb 2024
Print article
Image: The “attentive” neural network recognizes breast cancer with 99.6% accuracy (Photo courtesy of RUDN University)
Image: The “attentive” neural network recognizes breast cancer with 99.6% accuracy (Photo courtesy of RUDN University)

The likelihood of a favorable outcome for a breast cancer patient is greatly influenced by the stage at which the cancer is diagnosed. Histological examination is the benchmark for diagnosis, but its reliability can be affected by subjective interpretations and the quality of the tissue sample. Inaccuracies in these examinations can lead to incorrect diagnoses. Now, a team of mathematicians has developed a machine learning model that significantly enhances the accuracy of identifying cancer in histological images. The highlight of this model is the incorporation of an additional module that boosts the neural network's "attention" capability, enabling it to achieve near-perfect accuracy.

The mathematicians at RUDN University (Moscow, Russia) conducted tests on several convolutional neural networks and supplemented them with two convolutional attention modules. These modules are crucial for detecting objects within images. The model underwent training and testing using the BreakHis dataset, which comprises nearly 10,000 histological images at various scales, sourced from 82 patients. The most impressive performance came from a model that combined the DenseNet211 convolutional network with the attention modules, achieving a remarkable accuracy rate of 99.6%. The research team noted that the detection of cancerous formations is affected by image scale. This is because images differ in quality at various zoom levels, and cancerous formations appear differently. Therefore, during practical application, selecting the appropriate scale for image analysis must be a critical consideration.

“Computer classification of histological images will reduce the burden on doctors and increase the accuracy of tests. Such technologies will improve the treatment and diagnosis of breast cancer. Deep learning methods have shown promising results in medical image analysis problems in recent years,” said Ammar Muthanna, Ph.D., Director of the Scientific Center for Modeling Wireless 5G Networks at RUDN University. “The attention modules in the model improved feature extraction and the overall performance of the model. With their help, the model focused on significant areas of the image and highlighted the necessary information. It shows the importance of attention mechanisms in the analysis of medical images.”

Related Links:
RUDN University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.